The clinical toxicology of metamfetamine

References

• McEvoy GK. AHFS Drug Information 2010. Bethesda, MD: American Society of Health-System Pharmacists; 2010.
   Google Scholar
• Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Goodmand & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996.
   Google Scholar
• Cho AK. Ice – a new dosage form of an old drug. Science 1990; 249:631–634.
   PubMed Web of Science ®Google Scholar
• Hansch C, Leo A, Hoekman D. Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society; 1995.
   Google Scholar
• O'Neil MJ. The Merck Index. 14th ed. Whitehouse Station, NJ: Merck Research Laboratories; 2006.
   Google Scholar
• Perrin DD. Dissociation Constants of Organic Bases in Aqueous Solution. London: Butterworths; 1965.
   Google Scholar
• Sunshine I. Handbook of Analytical Toxicology. Cleveland, OH: Chemical Rubber Co; 1969.
   Google Scholar
• Heinonen EH, Anttila MI, Lammintausta RA. Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites. Clin Pharmacol Ther 1994; 56:742–749.
   PubMed Web of Science ®Google Scholar
• Bruneton J. Toxic Plants Dangerous to Humans and Animals. Hampshire, UK: Intercept Ltd; 1999.
   Google Scholar
• Suwaki H, Fukui S, Konuma K. Methamphetamine abuse in Japan: its 45 year history. In: Klee H, ed. Amphetamine Misuse. International Perspectives on Current Trends. Amsterdam: Harwood Academic Publishers; 1997:199–214.
   Google Scholar
• Editorial. Benzedrine sulfate “pep pills.” JAMA 1937; 108:1973–1974.
   Google Scholar
• Lemere F. The danger of amphetamine dependency. Am J Psychiatry 1966; 123:567–572.
   Google Scholar
• Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000; 32:137–141.
   PubMed Web of Science ®Google Scholar
• MMWR. Increasing morbidity and mortality associated with abuse of methamphetamine–United States, 1991–1994. MMWR Morb Mortal Wkly Rep 1995; 44:882–886.
   PubMedGoogle Scholar
• UNODC. 2009 World Drug Report. Vienna, Austria: United Nations Office on Drugs and Crime; 2009. http://www.unodc.org/documents/wdr/WDR_2009/WDR2009_eng_web.pdf. Accessed 5 March 2010.
   Google Scholar
• UNODC. United Nations Office on Drugs and Crime. World Drug Report 2000. New York: Oxford University Press; 2000.
   Google Scholar
• EMCDDA. Annual Report on the State of the Drugs Problem in Europe. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2009. http://www.emcdda.europa.eu/attachements.cfm/att_93236_EN_EMCDDA_AR2009_EN.pdf. Accessed 5 January 2010.
   Google Scholar
• Kulish N. Europe Fears That Meth Foothold Is Expanding. New York: New York Times; 2007:A1. http://www.nytimes.com/2007/11/23/world/europe/23meth.html?ref=world. Accessed 21 May 2010.
   Google Scholar
• Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006; 31:301–313.
   PubMed Web of Science ®Google Scholar
• Zolkowska D, Rothman RB, Baumann MH. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther 2006; 318:604–610.
   PubMed Web of Science ®Google Scholar
• Wise RA. Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction. Trends Neurosci 2009; 32:517–524.
   PubMed Web of Science ®Google Scholar
• Seiden LS, Sabol KE. Amphetamine – effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 1993; 33:639–677.
   PubMed Web of Science ®Google Scholar
• Venton BJ, Zhang H, Garris PA, Phillips PE, Sulzer D, Wightman RM. Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem 2004; 87:1284–1295.
   Web of Science ®Google Scholar
• Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75:406–433.
   PubMed Web of Science ®Google Scholar
• Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009; 60:379–407.
   PubMed Web of Science ®Google Scholar
• Fischer JF, Cho AK. Chemical release of dopamine from striatal homogenates – evidence for an exchange diffusion-model. J Pharmacol Exp Ther 1979; 208:203–209.
   PubMed Web of Science ®Google Scholar
• Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D-2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 2001; 21:5916–5924.
   PubMed Web of Science ®Google Scholar
• McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye WG, Alexander M, Dannals RF, Wong DF, Ricaurte GA. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008; 62:91–100.
   PubMed Web of Science ®Google Scholar
• Suzuki O, Hattori H, Asano M, Oya M, Katsumata Y. Inhibition of monoamine-oxidase by d-methamphetamine. Biochem Pharmacol 1980; 29:2071–2073.
   PubMed Web of Science ®Google Scholar
• Mandell AJ, Morgan M. Amphetamine induced increase in tyrosine hydroxylase activity. Nature 1970; 227:75–76.
   PubMed Web of Science ®Google Scholar
• Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 1998; 32:117–131.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 2003; 160:1699–1701.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377–382.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006; 63:90–100.
   PubMed Web of Science ®Google Scholar
• Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2:699–703.
   PubMed Web of Science ®Google Scholar
• Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 1980; 181:151–160.
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat-brain – a regional study. Brain Res 1980; 193:153–163.
   PubMed Web of Science ®Google Scholar
• Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, Perez-Reyes M. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 1992; 20:856–862.
   PubMed Web of Science ®Google Scholar
• Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 2003; 49:121–132.
   PubMed Web of Science ®Google Scholar
• Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci 2007; 1098:104–121.
   PubMed Web of Science ®Google Scholar
• Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther 2003; 74:475–486.
   PubMed Web of Science ®Google Scholar
• Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacol 2008; 33:1847–1855.
   PubMed Web of Science ®Google Scholar
• Perez-Reyes M, White WR, McDonald SA, Hill JM, Jeffcoat AR, Cook CE. Clinical effects of methamphetamine vapor inhalation. Life Sci 1991; 49:953–959.
   PubMed Web of Science ®Google Scholar
• Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993; 21:717–723.
   PubMed Web of Science ®Google Scholar
• Mendelson J, Jones RT, Upton R, Jacob P. Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther 1995; 57:559–568.
   PubMed Web of Science ®Google Scholar
• Franksson G, Anggård E. Plasma protein binding of amphetamine, catecholamines and related compounds. Acta Pharmacol Toxicol (Copenh) 1970; 28:209–214.
   PubMedGoogle Scholar
• Rivière GJ, Gentry WB, Owens SM. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 2000; 292:1042–1047.
   PubMed Web of Science ®Google Scholar
• Bartu A, Dusci LJ, Ilett KF. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009; 67:455–459.
   PubMed Web of Science ®Google Scholar
• Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 1997; 21:515–517.
   PubMed Web of Science ®Google Scholar
• Garcia-Bournissen F, Rokach B, Karaskov T, Koren G. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child Fetal Neonatal Ed 2007; 92:351–355.
   PubMed Web of Science ®Google Scholar
• Ariagno R, Karch SB, Middleberg R, Stephens BG, Valdesdapena M. Methamphetamine ingestion by a breast-feeding mother and her infants death – People V Henderson. JAMA 1995; 274:215–215.
   PubMed Web of Science ®Google Scholar
• Caldwell J. Metabolism of amphetamines in mammals. Drug Metab Rev 1976; 5:219–280.
   PubMed Web of Science ®Google Scholar
• Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 1997; 25:1059–1064.
   PubMed Web of Science ®Google Scholar
• Caldwell J, Dring LG, Williams RT. Metabolism of (14 C)methamphetamine in man, the guinea pig and the rat. Biochem J 1972; 129:11–22.
   PubMed Web of Science ®Google Scholar
• Shima N, Tsutsumi H, Kamata T, Nishikawa M, Katagi M, Miki A, Tsuchihashi H. Direct determination of glucuronide and sulfate of p‐hydroxymethamphetamine in methamphetamine users' urine. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830:64–70.
   PubMed Web of Science ®Google Scholar
• Shimosato K, Oda H, Ohmae M, Tomita M, Doi Y. Biphasic effects of alcohol drinking on methamphetamine metabolism in man. Alcohol Alcohol 1988; 23:351–357.
   PubMed Web of Science ®Google Scholar
• Shimosato K. Urinary excretion of p-hydroxylated methamphetamine metabolites in man. II. Effect of alcohol intake on methamphetamine metabolism. Pharmacol Biochem Behav 1988; 29:733–740.
   PubMed Web of Science ®Google Scholar
• Barnes AJ, Smith ML, Kacinko SL, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin Chem 2008; 54:172–180.
   PubMed Web of Science ®Google Scholar
• Beckett AH, Rowland M. Urinary excretion of methylamphetamine in man. Nature 1965; 206:1260–1261.
   PubMed Web of Science ®Google Scholar
• Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit 2004; 26:664–672.
   PubMed Web of Science ®Google Scholar
• Leffler EB, Spencer HM, Burger A. Dissociation constants of adrenergic amines. J Am Chem Soc 1951; 73:2611–2613.
   Web of Science ®Google Scholar
• Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT. Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 2006; 80:403–420.
   PubMed Web of Science ®Google Scholar
• Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep 1993; 16:306–317.
   PubMed Web of Science ®Google Scholar
• Shappell SA, Kearns GL, Valentine JL, Neri DF, DeJohn CA. Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol 1996; 36:1051–1063.
   PubMed Web of Science ®Google Scholar
• Hendrickson RG, Horowitz BZ, Norton RL, Notenboom H. “Parachuting” meth: a novel delivery method for methamphetamine and delayed-onset toxicity from “body stuffing.” Clin Toxicol (Phila) 2006; 44:379–382.
   PubMed Web of Science ®Google Scholar
• Burchell SA, Ho HC, Yu M, Margulies DR. Effects of methamphetamine on trauma patients: a cause of severe metabolic acidosis? Crit Care Med 2000; 28:2112–2115.
   PubMed Web of Science ®Google Scholar
• Cantrell FL, Breckenridge HM, Jost P. Transrectal methamphetamine use: a novel route of exposure. Ann Intern Med 2006; 145:78–79.
   PubMed Web of Science ®Google Scholar
• Cravey RH, Baselt RC. Methamphetamine poisoning. J Forensic Sci Soc 1968; 8:118–120.
   PubMedGoogle Scholar
• Gullatt R. Acute methamphetamine poisoning in a child. South Med J 1957; 50:1068.
   PubMedGoogle Scholar
• Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 1991; .265:1152–1154.
   PubMed Web of Science ®Google Scholar
• Kamijo Y, Soma K, Nishida M, Namera A, Ohwada T. Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol 2002; 44:216–217.
   PubMedGoogle Scholar
• Kashani J, Ruha AM. Methamphetamine toxicity secondary to intravaginal body stuffing. J Toxicol Clin Toxicol 2004; 42:987–989.
   PubMed Web of Science ®Google Scholar
• Logan BK, Weiss EL, Harruff RC. Case report: distribution of methamphetamine in a massive fatal ingestion. J Forensic Sci 1996; 41:322–323.
   PubMed Web of Science ®Google Scholar
• Malay ME. Unintentional methamphetamine intoxication. J Emerg Nurs 2001; 27:13–16.
   PubMedGoogle Scholar
• Olsen ER. Intracranial hemorrhage and amphetamine usage. Review of the effects of amphetamines on the central nervous system. Angiology 1977; 28:464–471.
   PubMed Web of Science ®Google Scholar
• Yu YJ, Cooper DR, Wellenstein DE, Block B. Cerebral angiitis and intracerebral hemorrhage associated with methamphetamine abuse. Case report. J Neurosurg 1983; 58:109–111.
   PubMed Web of Science ®Google Scholar
• Srikanth S, Barua R, Ambrose J. Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 2008; 109:188–192.
   PubMed Web of Science ®Google Scholar
• Waksman J, Taylor RN, Bodor GS, Daly FF, Jolliff HA, Dart RC. Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc 2001; 76:323–326.
   PubMed Web of Science ®Google Scholar
• Zalis EG, Parmley LF. Fatal amphetamine poisoning. Arch Intern Med 1963; 112:822–826.
   PubMed Web of Science ®Google Scholar
• Lukes SA. Intracerebral hemorrhage from an arteriovenous malformation after amphetamine injection. Arch Neurol 1983; 40:60–61.
   PubMed Web of Science ®Google Scholar
• Kendrick WC, Hull AR, Knochel JP. Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 1977; 86:381–387.
   PubMed Web of Science ®Google Scholar
• Gupta M, Bailey S, Lovato LM. Bottoms up: methamphetamine toxicity from an unusual route. West J Emerg Med 2009; 10:58–60.
   PubMedGoogle Scholar
• Furst SR, Fallon SP, Reznik GN, Shah PK. Myocardial infarction after inhalation of methamphetamine. N Engl J Med 1990; 323:1147–1148.
   PubMed Web of Science ®Google Scholar
• Gary NE, Saidi P. Methamphetamine intoxication. A speedy new treatment. Am J Med 1978; 64:537–540.
   PubMed Web of Science ®Google Scholar
• Rhee KJ, Albertson TE, Douglas JC. Choreoathetoid disorder associated with amphetamine-like drugs. Am J Emerg Med 1988; 6:131–133.
   PubMed Web of Science ®Google Scholar
• Gospe SM Jr. Transient cortical blindness in an infant exposed to methamphetamine. Ann Emerg Med 1995; 26:380–382.
   PubMed Web of Science ®Google Scholar
• Kane FJ Jr, Keeler MH, Reifler CB. Neurological crises following methamphetamine. JAMA 1969; 210:556–557.
   PubMed Web of Science ®Google Scholar
• Nagorka AR, Bergeson PS. Infant methamphetamine toxicity posing as scorpion envenomation. Pediatr Emerg Care 1998; 14:350–351.
   PubMed Web of Science ®Google Scholar
• Molina NM, Jejurikar SG. Toxicological findings in a fatal ingestion of methamphetamine. J Anal Toxicol 1999; 23:67–68.
   PubMed Web of Science ®Google Scholar
• Delgado JH, Caruso MJ, Waksman JC, Honigman B, Stillman D. Acute, transient urinary retention from combined ecstasy and methamphetamine use. J Emerg Med 2004; 26:173–175.
   PubMed Web of Science ®Google Scholar
• Stafford CR, Bogdanoff BM, Green L, Spector HB. Mononeuropathy multiplex as a complication of amphetamine angiitis. Neurology 1975; 25:570–572.
   PubMed Web of Science ®Google Scholar
• Smith DE. Physical vs. psychological dependence and tolerance in high-dose methamphetamine abuse. Clin Toxicol 1969; 2:99–103.
   Web of Science ®Google Scholar
• Bingham C, Beaman M, Nicholls AJ, Anthony PP. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine (“ecstasy”). Nephrol Dial Transplant 1998; 13:2654–2655.
   PubMed Web of Science ®Google Scholar
• Chan P, Chen JH, Lee MH, Deng JF. Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol 1994; 32:147–155.
   PubMed Web of Science ®Google Scholar
• Smith DE, Fischer CM. An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury. Clin Toxicol 1970; 3:117–124.
   PubMed Web of Science ®Google Scholar
• Ruha AM, Yarema MC. Pharmacologic treatment of acute pediatric methamphetamine toxicity. Pediatr Emerg Care 2006; 22:782–785.
   PubMed Web of Science ®Google Scholar
• Matteucci MJ, Auten JD, Crowley B, Combs D, Clark RF. Methamphetamine exposures in young children. Pediatr Emerg Care 2007; 23:638–640.
   PubMed Web of Science ®Google Scholar
• Kolecki P. Inadvertent methamphetamine poisoning in pediatric patients. Pediatr Emerg Care 1998; 14:385–387.
   PubMed Web of Science ®Google Scholar
• Guharoy R, Medicis J, Chol S, Stalder B, Kusiowski K, Allen A. Methamphetamine overdose: experience with six cases. Vet Hum Toxicol 1999; 41:28–30.
   PubMedGoogle Scholar
• West PL, McKeown NJ, Hendrickson RG. Methamphetamine body stuffers: an observational case series. Ann Emerg Med 2010; 55:190–197.
   PubMed Web of Science ®Google Scholar
• Ago M, Ago K, Hara K, Kashimura S, Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg Med 2006; 8:235–239.
   PubMedGoogle Scholar
• Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17:469–471.
   PubMed Web of Science ®Google Scholar
• Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970; 283:1003–1011.
   PubMed Web of Science ®Google Scholar
• Yen DJ, Wang SJ, Ju TH, Chen CC, Liao KK, Fuh JL, Hu HH. Stroke associated with methamphetamine inhalation. Eur Neurol 1994; 34:16–22.
   PubMed Web of Science ®Google Scholar
• Wako E, LeDoux D, Mitsumori L, Aldea GS. The emerging epidemic of methamphetamine-induced aortic dissections. J Card Surg 2007; 22:390–393.
   PubMed Web of Science ®Google Scholar
• Watts DJ, McCollester L. Methamphetamine-induced myocardial infarction with elevated troponin I. Am J Emerg Med 2006; 24:132–134.
   PubMed Web of Science ®Google Scholar
• Nestor TA, Tamamoto WI, Kam TH, Schultz T. Crystal methamphetamine-induced acute pulmonary edema: a case report. Lancet 1989; 334:1277–1278.
   Google Scholar
• Koff RS, Widrich WC, Robbins AH. Necrotizing angiitis in a methamphetamine user with hepatitis B – angiographic diagnosis, five-month follow-up results and localization of bleeding site. N Engl J Med 1973; 288:946–947.
   PubMed Web of Science ®Google Scholar
• Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999; 44:359–368.
   PubMed Web of Science ®Google Scholar
• Pilgrim JL, Gerostamoulos D, Drummer OH, Bollmann M. Involvement of amphetamines in sudden and unexpected death. J Forensic Sci 2009; 54:478–485.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Naim M, Helfaer MA. A 14-year-old girl with agitation and hyperthermia. Pediatr Emerg Care 2006; 22:676–679.
   PubMed Web of Science ®Google Scholar
• Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol 2003; 41:981–986.
   PubMed Web of Science ®Google Scholar
• Farnsworth TL, Brugger CH, Malters P. Myocardial infarction after intranasal methamphetamine. Am J Health Syst Pharm 1997; 54:586–587.
   PubMed Web of Science ®Google Scholar
• Derlet RW, Rice P, Horowitz BZ, Lord RV. Amphetamine toxicity experience with 127 cases. J Emerg Med 1989; 7:157–162.
   PubMedGoogle Scholar
• Wijetunga M, Bhan R, Lindsay J, Karch S. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J 2004; 63:8–13.
   PubMedGoogle Scholar
• Kanwar M, Gill N. Spontaneous multivessel coronary artery dissection. J Invasive Cardiol 2010; 22:E5–E6.
   PubMedGoogle Scholar
• Haning W, Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction 2007; 102:70–75.
   PubMed Web of Science ®Google Scholar
• Sperling LS, Horowitz JL. Methamphetamine-induced choreoathetosis and rhabdomyolysis. Ann Intern Med 1994; 121:986.
   PubMed Web of Science ®Google Scholar
• Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med 2003; 24:369–373.
   PubMed Web of Science ®Google Scholar
• Kalant H, Kalant OJ. Death in amphetamine users – causes and rates. Can Med Assoc J 1975; 112:299–304.
   PubMed Web of Science ®Google Scholar
• Horiguchi T, Hori S, Shinozawa Y, Fujishima S, Kimura H, Yokoyama M, Sasaki J, Takatsuki S, Suzuki M, Yamazaki M, Aikawa N. A case of traumatic shock complicated by methamphetamine intoxication. Intensive Care Med 1999; 25:758–760.
   PubMed Web of Science ®Google Scholar
• Schaiberger PH, Kennedy TC, Miller FC, Gal J, Petty TL. Pulmonary hypertension associated with long-term inhalation of “crank” methamphetamine. Chest 1993; 104:614–616.
   PubMed Web of Science ®Google Scholar
• Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 1989; 12:725–727.
   PubMed Web of Science ®Google Scholar
• Nishida N, Ikeda N, Kudo K, Esaki R. Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report. Med Sci Law 2003; 43:267–271.
   PubMed Web of Science ®Google Scholar
• Matoba R, Onishi S, Shikata I. Cardiac lesions in cases of sudden death in methamphetamine abusers. Heart Vessels 1985; 1:298–300.
   Google Scholar
• Rajs J, Falconer B. Cardiac lesions in intravenous drug addicts. Forensic Sci Int 1979; 13:193–209.
   PubMed Web of Science ®Google Scholar
• Inoue H, Ikeda N, Kudo K, Ishida T, Terada M, Matoba R. Methamphetamine-related sudden death with a concentration which was of a “toxic level.” Leg Med 2006; 8:150–155.
   PubMedGoogle Scholar
• Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB, Alimineti K, Kimata C, Schatz IJ. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 2007; 120:165–171.
   PubMed Web of Science ®Google Scholar
• Ago M, Kazutoshi A, Ogata M. Determination of methamphetamine in sudden death of a traffic accident inpatient by blood and hair analyses. Leg Med 2009; 11:S568–S569.
   PubMedGoogle Scholar
• Mori A, Suzuki H, Ishiyama I. Three cases of acute methamphetamine intoxication–analysis of optically active methamphetamine [Japanese]. Nihon Hoigaku Zasshi 1992; 46:266–270.
   PubMedGoogle Scholar
• Herr RD, Caravati EM. Acute transient ischemic colitis after oral methamphetamine ingestion. Am J Emerg Med 1991; 9:406–409.
   PubMed Web of Science ®Google Scholar
• Johnson TD, Berenson MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol 1991; 13:687–689.
   PubMed Web of Science ®Google Scholar
• Holubar SD, Hassinger JP, Dozois EJ, Masuoka HC. Methamphetamine colitis. A rare case of ischemic colitis in a young patient. Arch Surg 2009; 144:780–782.
   PubMed Web of Science ®Google Scholar
• Dirkx CA, Gerscovich EO. Sonographic findings in methamphetamine-induced ischemic colitis. J Clin Ultrasound 1998; 26:479–482.
   PubMed Web of Science ®Google Scholar
• Yarnell PR. “Speed:” headache and hematoma. Headache 1977; 17:69–70.
   PubMed Web of Science ®Google Scholar
• Ohta K, Mori M, Yoritaka A, Okamoto K, Kishida S. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med 2005; 28:165–167.
   PubMed Web of Science ®Google Scholar
• Margolis MT, Newton TH. Methamphetamine (“speed”) arteritis. Neuroradiology 1971; 2:179–182.
   PubMed Web of Science ®Google Scholar
• Edwards KR. Hemorrhagic complications of cerebral arteritis. Arch Neurol 1977; 34:549–552.
   PubMed Web of Science ®Google Scholar
• Shibata S, Mori K, Sekine I, Suyama H. Subarachnoid and intracerebral hemorrhage associated with necrotizing angiitis due to methamphetamine abuse–an autopsy case. Neurol Med Chir (Tokyo) 1991; 31:49–52.
   PubMedGoogle Scholar
• Leithäuser B, Langheinrich AC, Rau WS, Tillmanns H, Matthias FR. A 22-year-old woman with lower limb arteriopathy. Buerger's disease, or methamphetamine- or cannabis-induced arteritis? Heart Vessels 2005; 20:39–43.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Hayashi T, Ishida Y, Tsuneyama K, Kimura A, Kondo T. A fatal case of pontine hemorrhage related to methamphetamine abuse. J Forensic Leg Med 2007; 14:444–447.
   PubMedGoogle Scholar
• Selmi F, Davies KG, Sharma RR, Neal JW. Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations. Br J Neurosurg 1995; 9:93–96.
   PubMed Web of Science ®Google Scholar
• Rothrock JF, Rubenstein R, Lyden PD. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988; 38:589–592.
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Ogawa A, Kita H, Kayama T, Sakurai Y, Suzuki J. Intracerebral hemorrhage and characteristic angiographic changes associated with methamphetamine – a case report [Japanese]. No To Shinkei 1986; 38:967–971.
   PubMedGoogle Scholar
• Davis GG, Swalwell CI. Acute aortic dissections and ruptured berry aneurysms associated with methamphetamine abuse. J Forensic Sci 1994; 39:1481–1485.
   PubMed Web of Science ®Google Scholar
• McIntosh A, Hungs M, Kostanian V, Yu W. Carotid artery dissection and middle cerebral artery stroke following methamphetamine use. Neurology 2006; 67:2259–2260.
   PubMed Web of Science ®Google Scholar
• Weiss SR, Raskind R, Morganstern NL, Pytlyk PJ, Baiz TC. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (“speed”). Int Surg 1970; 53:123–127.
   PubMedGoogle Scholar
• Swalwell CI, Davis GG. Methamphetamine as a risk factor for acute aortic dissection. J Forensic Sci 1999; 44:23–26.
   PubMed Web of Science ®Google Scholar
• McGee SM, McGee DN, McGee MB. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am J Forensic Med Pathol 2004; 25:334–337.
   PubMed Web of Science ®Google Scholar
• Hall CD, Blanton DE, Scatliff JH, Morris CE. Speed kills: fatality from the self-administration of methamphetamine intravenously. South Med J 1973; 66:650–652.
   PubMed Web of Science ®Google Scholar
• Delaney P, Estes M. Intracranial hemorrhage with amphetamine abuse. Neurology 1980; 30:1125–1128.
   PubMed Web of Science ®Google Scholar
• Ho EL, Josephson SA, Lee HS, Smith WS. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 2009; 10:295–305.
   PubMed Web of Science ®Google Scholar
• Catanzarite VA, Stein DA. “Crystal” and pregnancy–methamphetamine-associated maternal deaths. West J Med 1995; 162:454–457.
   PubMedGoogle Scholar
• Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Ohba S, Ichikizaki K. Subcortical hemorrhage caused by methamphetamine abuse: efficacy of the triage system in the differential diagnosis–case report. Neurol Med Chir (Tokyo) 2003; 43:82–84.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Shimura T, Hibuchi H, Tsuji Y, Yajima K, Nakazawa S. Clinicopathological studies of spontaneous intracerebral hematoma [Japanese]. No Shinkei Geka 1981; 9:1373–1381.
   PubMedGoogle Scholar
• Moriya F, Hashimoto Y. A case of fatal hemorrhage in the cerebral ventricles following intravenous use of methamphetamine. Forensic Sci Int 2002; 129:104–109.
   PubMed Web of Science ®Google Scholar
• Lan KC, Lin YF, Yu FC, Lin CS, Chu P. Clinical manifestations and prognostic features of acute methamphetamine intoxication (abstract). J Formos Med Assoc 1998; 97:528–533.
   PubMed Web of Science ®Google Scholar
• Takekawa K, Ohmori T, Kido A, Oya M. Methamphetamine body packer: acute poisoning death due to massive leaking of methamphetamine. J Forensic Sci 2007; 52:1219–1222.
   PubMed Web of Science ®Google Scholar
• Li RB, Guan DW, Zhu BL, Zhang GH, Zhao R. Death from accidental poisoning of methamphetamine by leaking into alimentary tract in drug traffic: a case report. Leg Med 2009; 11:S491–S493.
   PubMedGoogle Scholar
• Uemura K, Sorimachi Y, Yashiki M, Yoshida K. Two fatal cases involving concurrent use of methamphetamine and morphine. J Forensic Sci 2003; 48:1179–1181.
   PubMed Web of Science ®Google Scholar
• Saito T, Takeichi S, Nakajima Y, Yukawa N, Osawa M. Fatal methamphetamine poisoning in police custody. J Clin Forensic Med 1996; 3:183–185.
   PubMedGoogle Scholar
• Katsumata S, Sato K, Kashiwade H, Yamanami S, Zhou H, Yonemura I, Nakajima H, Hasekura H. Sudden death due presumably to internal use of methamphetamine. Forensic Sci Int 1993; 62:209–215.
   PubMed Web of Science ®Google Scholar
• Kojima T, Une I, Yashiki M, Noda J, Sakai K, Yamamoto K. A fatal methamphetamine poisoning associated with hyperpyrexia. Forensic Sci Int 1984; 24:87–93.
   PubMed Web of Science ®Google Scholar
• Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, Horita N, Kaneko T. Patients with methamphetamine psychosis admitted to a psychiatric-hospital in Japan – a preliminary-report. Acta Psychiatr Scand 1994; 89:428–432.
   PubMed Web of Science ®Google Scholar
• Dore G, Sweeting M. Drug-induced psychosis associated with crystalline methamphetamine. Australas Psychiatry 2006; 14:86–89.
   PubMedGoogle Scholar
• Yamamoto N, Oda T, Inada T. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Psychiatry Clin Neurosci 2007; 61:691–694.
   PubMed Web of Science ®Google Scholar
• Jackson JG. Hazards of smokable methamphetamine. N Engl J Med 1989; 321:907.
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Hara T. Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients. Psychopathology 1998; 31:131–137.
   PubMed Web of Science ®Google Scholar
• Yui K, Goto K, Ikemoto S, Ishiguro T. Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function. J Clin Psychopharmacol 1997; 17:34–43.
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Lubman DI, Hides L. Hostility among methamphetamine users experiencing psychotic symptoms. Am J Addict 2008; 17:235–240.
   PubMed Web of Science ®Google Scholar
• Nestor TA, Tamamoto WI, Kam TH, Schultz T. Crystal methamphetamine-induced acute pulmonary edema: a case report. Hawaii Med J 1989; 48:457–458.
   PubMedGoogle Scholar
• Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 2006; 130:1657–1663.
   PubMed Web of Science ®Google Scholar
• Wallace RT, Brown GC, Benson W, Sivalingham A. Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. Am J Ophthalmol 1992; 114:158–160.
   PubMed Web of Science ®Google Scholar
• Shaw HE Jr, Lawson JG, Stulting RD. Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation. J Clin Neuroophthalmol 1985; 5:169–176.
   PubMedGoogle Scholar
• Poulsen EJ, Mannis MJ, Chang SD. Keratitis in methamphetamine abusers. Cornea 1996; 15:477–482.
   PubMed Web of Science ®Google Scholar
• Chuck RS, Williams JM, Goldberg MA, Lubniewski AJ. Recurrent corneal ulcerations associated with smokeable methamphetamine abuse. Am J Ophthalmol 1996; 121:571–572.
   PubMed Web of Science ®Google Scholar
• Kumar RL, Kaiser PK, Lee MS. Crystalline retinopathy from nasal ingestion of methamphetamine. Retina 2006; 26:823–824.
   PubMed Web of Science ®Google Scholar
• Richards JR, Johnson EB, Stark RW, Derlet RW. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 1999; 17:681–685.
   PubMed Web of Science ®Google Scholar
• Kiely E, Lee CJ, Marinetti L. A fatality from an oral ingestion of methamphetamine. J Anal Toxicol 2009; 33:557–560.
   PubMed Web of Science ®Google Scholar
• Ellison JM, Dobies DF. Methamphetamine abuse presenting as dysuria following urethral insertion of tablets. Ann Emerg Med 1984; 13:198–200.
   PubMed Web of Science ®Google Scholar
• Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl) 2005; 182:426–435.
   PubMed Web of Science ®Google Scholar
• Newton TF, De La Garza R II, Kalechstein AD, Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav 2005; 82:90–97.
   PubMed Web of Science ®Google Scholar
• Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacol 2006; 31:1537–1544.
   PubMed Web of Science ®Google Scholar
• Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol 2008; 11:1037–1045.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Wells LT. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacol 2000; 22:504–512.
   PubMed Web of Science ®Google Scholar
• Fleury G, De la Garza R, Mahoney JJ, Evans SE, Newton TF. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. Am J Addict 2008; 17:103–110.
   PubMed Web of Science ®Google Scholar
• De La Garza R, Shoptaw S, Newton TF. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 2008; 11:729–741.
   PubMed Web of Science ®Google Scholar
• De la Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav 2009; 94:186–193.
   PubMed Web of Science ®Google Scholar
• De la Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend 2010; 106:173–180.
   PubMed Web of Science ®Google Scholar
• Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12:245–258.
   PubMed Web of Science ®Google Scholar
• Silber BY, Croft RJ, Papafotiou K, Stough C. The acute effects of d‐amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology (Berl) 2006; 187:154–169.
   PubMed Web of Science ®Google Scholar
• Bell DS. Experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973; 29:35–40.
   PubMed Web of Science ®Google Scholar
• Birkhahn HJ, Heifetz M. Accidental intra-arterial injection of amphetamine – unusual hazard of drug-addiction – case report. Br J Anaesth 1973; 45:761–763.
   PubMed Web of Science ®Google Scholar
• Davis GG, Swalwell CI. The incidence of acute cocaine or methamphetamine intoxication in deaths due to ruptured cerebral (berry) aneurysms. J Forensic Sci 1996; 41:626–628.
   PubMed Web of Science ®Google Scholar
• Kase CS. Intracerebral hemorrhage: non-hypertensive causes. Stroke 1986; 17:590–595.
   PubMed Web of Science ®Google Scholar
• Prior FH, Isbister GK, Dawson AH, Whyte IM. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine. Med J Aust 2002; 176:240–241.
   PubMed Web of Science ®Google Scholar
• Kuczenski R, Segal DS, Cho AK, Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 1995; 15:1308–1317.
   PubMed Web of Science ®Google Scholar
• Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA). Lancet 1996; 347:1052.
   PubMed Web of Science ®Google Scholar
• Kaye S, Darke S, Duflou J, McKetin R. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 2008; 103:1353–1360.
   PubMed Web of Science ®Google Scholar
• Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 2000; 9:222–2231.
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24:6028–6036.
   PubMed Web of Science ®Google Scholar
• Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000; 54:1344–1349.
   PubMed Web of Science ®Google Scholar
• Rudnicki SA, Archer RL, Labib BT. Motor neuron disease in methamphetamine abusers. Amyotroph Lateral Scler 2007; 8:126–127.
   PubMed Web of Science ®Google Scholar
• Iwanami A, Kato N, Nakatani Y. P300 in methamphetamine psychosis. Biol Psychiatry 1991; 30:726–730.
   PubMed Web of Science ®Google Scholar
• Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13:181–190.
   PubMed Web of Science ®Google Scholar
• Israel JA, Lee K. Amphetamine usage and genital self-mutilation. Addiction 2002; 97:1215–1218.
   PubMed Web of Science ®Google Scholar
• Winslow BT, Voorhees KI, Pehl KA. Methamphetamine abuse. Am Fam Physician 2007; 76:1169–1174.
   PubMed Web of Science ®Google Scholar
• Hamamoto DT, Rhodus NL. Methamphetamine abuse and dentistry. Oral Dis 2009; 15:27–37.
   PubMed Web of Science ®Google Scholar
• Shaner JW, Kimmes N, Saini T, Edwards P. “Meth mouth:” rampant caries in methamphetamine abusers. AIDS Patient Care STDS 2006; 20:146–150.
   PubMed Web of Science ®Google Scholar
• Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW. Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) 2001; 155:397–404.
   PubMed Web of Science ®Google Scholar
• Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA 1967; 201:305–309.
   PubMed Web of Science ®Google Scholar
• Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005; 13:141–154.
   PubMed Web of Science ®Google Scholar
• Barr AM, Markou A, Phillips AG. A “crash” course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 2002; 23:475–482.
   PubMed Web of Science ®Google Scholar
• Gawin FH, Ellinwood EH. Cocaine and other stimulants – actions, abuse, and treatment. N Engl J Med 1988; 318:1173–1182.
   PubMed Web of Science ®Google Scholar
• Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004; 13:248–255.
   PubMed Web of Science ®Google Scholar
• McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100:1320–1329.
   PubMed Web of Science ®Google Scholar
• Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010; 69:578–592.
   PubMed Web of Science ®Google Scholar
• Stek AM, Baker S, Fisher BK, Lang U, Clark KE. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol 1995; 173:1592–1598.
   PubMed Web of Science ®Google Scholar
• Burchfield DJ, Lucas VW, Abrams RM, Miller RL, Devane CL. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA 1991; 265:1968–1973.
   PubMed Web of Science ®Google Scholar
• Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 2003; 24:17–23.
   PubMed Web of Science ®Google Scholar
• Little BB, Snell LM, Gilstrap LC III. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988; 72:541–544.
   PubMed Web of Science ®Google Scholar
• Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118:1149–1156.
   PubMed Web of Science ®Google Scholar
• Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Della Grotta S, Liu J, Lester B. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL). Matern Child Health J 2006; 10:293–302.
   PubMed Web of Science ®Google Scholar
• Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115:770–778.
   PubMed Web of Science ®Google Scholar
• Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L. Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 2009; 72:2068–2075.
   PubMed Web of Science ®Google Scholar
• Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004; 132:95–106.
   PubMed Web of Science ®Google Scholar
• Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111:571–578.
   PubMed Web of Science ®Google Scholar
• Billing L, Eriksson M, Steneroth G, Zetterström R. Pre-school children of amphetamine-addicted mothers. I. Somatic and psychomotor development. Acta Paediatr Scand 1985; 74:179–184.
   PubMed Web of Science ®Google Scholar
• Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. The Influence of environmental factors on behavioral-problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 1994; 18:3–9.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Billing L, Steneroth G, Zetterström R. Health and development of 8-year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr Scand 1989; 78:944–949.
   PubMed Web of Science ®Google Scholar
• Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterström R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr 1996; 85:204–208.
   PubMed Web of Science ®Google Scholar
• Suchard JR, Curry SC. Methamphetamine toxicity. Pediatr Emerg Care 1999; 15:306.
   PubMed Web of Science ®Google Scholar
• McKinney PE, Palmer RB. Amphetamines and derivatives. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Philadelphia PA: Elsevier Mosby; 2005:761–766.
   Google Scholar
• D'Nicuola J, Jones R, Levine B, Smith ML. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. J Anal Toxicol 1992; 16:211–213.
   PubMed Web of Science ®Google Scholar
• Roberge RJ, Luellen JR, Reed S. False-positive amphetamine screen following a trazodone overdose. J Toxicol Clin Toxicol 2001; 39:181–182.
   PubMed Web of Science ®Google Scholar
• Grinstead GF. Ranitidine and high-concentrations of phenylpropanolamine cross react in the emit monoclonal amphetamine methamphetamine assay. Clin Chem 1989; 35:1998–1999.
   PubMed Web of Science ®Google Scholar
• Valentine JL, Middleton R. GC-MS identification of sympathomimetic amine drugs in urine: rapid methodology applicable for emergency clinical toxicology. J Anal Toxicol 2000; 24:211–222.
   PubMed Web of Science ®Google Scholar
• McKinney PE, Tomaszewski C, Phillips S, Brent J, Kulig K. Methamphetamine toxicity prevented by activated charcoal in a mouse model. Ann Emerg Med 1994; 24:220–223.
   PubMed Web of Science ®Google Scholar
• Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43:61–87.
   PubMed Web of Science ®Google Scholar
• Seger D, Muelenbelt J. Position paper: ipecac syrup. J Toxicol Clin Toxicol 2004; 42:133–143.
   PubMedGoogle Scholar
• Wetli CV, Mittleman RE. The body packer syndrome – toxicity following ingestion of illicit drugs packaged for transportation. J Forensic Sci 1981; 26:492–500.
   PubMed Web of Science ®Google Scholar
• Roberts JR, Price D, Goldfrank L, Hartnett L. The bodystuffer syndrome – a clandestine form of drug overdose. Am J Emerg Med 1986; 4:24–27.
   PubMed Web of Science ®Google Scholar
• Booker RJ, Smith JE, Rodger MP. Packers, pushers and stuffers-managing patients with concealed drugs in UK emergency departments: a clinical and medicolegal review. Emerg Med J 2009; 26:316–320.
   PubMed Web of Science ®Google Scholar
• Position paper: whole bowel irrigation. J Toxicol Clin Toxicol 2004; 42:843–854.
   PubMed Web of Science ®Google Scholar
• Marc B, Baud FJ, Maisonblanche P, Leporc P, Garnier M, Gherardi R. Cardiac monitoring during medical-management of cocaine body packers. J Toxicol Clin Toxicol 1992; 30:387–397.
   PubMed Web of Science ®Google Scholar
• Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 8: advanced challenges in resuscitation: section 2: toxicology in ECC. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102:1223–1228.
   Google Scholar
• Joint Formulary Committee. British National Formulary 59. London: Pharmaceutical Press; 2010.
   Google Scholar
• Derlet RW, Albertson TE, Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 1990; 36:745–749.
   PubMed Web of Science ®Google Scholar
• Richards DA, Tuckman J, Prichard BN. Assessment of alpha-adrenoceptor and beta-adrenoceptor blocking actions of labetalol. Br J Clin Pharmacol 1976; 3:849–855.
   PubMed Web of Science ®Google Scholar
• Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emerg Med Australas 2008; 20:391–402.
   PubMed Web of Science ®Google Scholar
• Brogan WC, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991; 18:581–586.
   PubMed Web of Science ®Google Scholar
• Hollander JE, Hoffman RS, Gennis P, Fairweather P, Disano MJ, Schumb DA, Feldman JA, Fish SS, Dyer S, Wax P, Whelan C, Schwarzwald E. Nitroglycerin in the treatment of cocaine-associated chest pain – clinical safety and efficacy. J Toxicol Clin Toxicol 1994; 32:243–256.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, Kerns W, Martin TG, Ross MP. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 37:S78–S90.
   PubMed Web of Science ®Google Scholar
• Knott JC, Isbister GK. Sedation of agitated patients in the emergency department. Emerg Med Australas 2008; 20:97–100.
   PubMed Web of Science ®Google Scholar
• Downes MA, Healy P, Page CB, Bryant JL, Isbister GK. Structured team approach to the agitated patient in the emergency department. Emerg Med Australas 2009; 21:196–202.
   PubMed Web of Science ®Google Scholar
• Spain D, Crilly J, Whyte I, Jenner L, Carr V, Baker A. Safety and effectiveness of high-dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimuant-affected patients. Emerg Med Australas 2008; 20:112–120.
   PubMed Web of Science ®Google Scholar
• Whelan KR, Dargan PI, Jones AL, O'Connor N. Atypical antipsychotics not recommended for control of agitation in the emergency department. Emerg Med J 2004; 21:649.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003; 20:339–346.
   PubMed Web of Science ®Google Scholar
• Dubin WR, Weiss KJ, Dorn JM. Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmacol 1986; 6:210–222.
   PubMed Web of Science ®Google Scholar
• Chiang WK. Amphetamines. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland M, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw-Hill; 2006:1118–1132.
   Google Scholar
• Henry JA. Amphetamines. In: Ford MD, Delaney KA, Ling LJ, Erickson T, eds. Clinical Toxicology. Philadelphia, PA: Saunders Company; 2001:620–626.
   Google Scholar
• Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007; 186:336–339.
   PubMed Web of Science ®Google Scholar
• Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med 1994; 24:68–76.
   Google Scholar
• Richards Jr, Derlet RW, Duncan DR. Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone. Eur J Emerg Med 1997; 4:130–135.
   PubMedGoogle Scholar
• Richards Jr, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med 1998; 16:567–573.
   PubMedGoogle Scholar
• Bostwick DG. Amphetamine induced cerebral vasculitis. Hum Pathol 1981; 21:1030–1033.
   Google Scholar
• Kessler JT, Jortner BS, Adapon BD. Cerebral vasculitis in a drug abuser. J Clin Psychiatry 1978; 39:559–564.
   PubMed Web of Science ®Google Scholar
• Nisijima K, Shioda K, Yoshino T, Takano K, Kato S. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 2003; 43:155–164.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352:1112–1120.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 2007; 187:361–365.
   PubMed Web of Science ®Google Scholar
• Isbister GK. Comment: serotonin syndrome, mydriasis, and cyproheptadine. Ann Pharmacother 2001; 35:1672–1673.
   PubMed Web of Science ®Google Scholar
• Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG. Serotonin syndrome resulting from drug interactions. Med J Aust 1998; 169:523–525.
   PubMed Web of Science ®Google Scholar
• Richards JR, Bretz SW, Johnson EB, Turnipseed SD, Brofeldt BT, Derlet RW. Methamphetamine abuse and emergency department utilization. West J Med 1999; 170:198–202.
   PubMedGoogle Scholar
• Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis – an overview for clinicians. Crit Care 2005; 9:158–169.
   PubMed Web of Science ®Google Scholar
• Bosch X, Poch E, Grau JM. Rabdomyolysis and acute kidney injury. N Engl J Med 2009; 361:62–72.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamine. West J Med 1999; 170:214–219.
   PubMedGoogle Scholar
• Hutchaleelaha A, Mayersohn M. Influence of activated charcoal on the disposition kinetics of methamphetamine enantiomers in the rat following intravenous dosing. J Pharm Sci 1996; 85:541–545.
   PubMed Web of Science ®Google Scholar